Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1941468
PUBLISHER: Grand View Research | PRODUCT CODE: 1941468
Nootropics Market Size, Share & Trends Analysis Report By Form, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
PUBLISHED:
PAGES: 80 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Nootropics Market Summary
The global nootropics market size was valued at USD 5.45 billion in 2025 and is anticipated to reach USD 11.48 billion by 2033, growing at a CAGR of 9.1% from 2026 to 2033. The industry is expected to expand at a rapid pace over the forecast period on account of technological advancements as well as modernization in the field.
Rising consumer spending on various healthcare as well as wellness products is expected to fuel industry growth over the forecast period. In addition, cost-effectiveness as well as easy accessibility to these products are further expected to boost product needs among consumers.
The demand for natural and plant-based nootropics has increased with growing interest in holistic health. These compounds are recommended because they are sourced from plants and are in line with natural, sustainable, and ethical wellness practices. In keeping with the holistic health concept, they are viewed as a means of improving cognitive performance while encouraging balance between the mind and body. This market surge is a result of the rising consumer focus on health and wellness. With the increasing number of students attending college as well as a workforce that demands better qualifications due to the low unemployment rate, prospective candidates have been seeking natural ways to gain a competitive advantage and improve their performance.
The rising trend of cognitive enhancement among healthy consumers for academic and professional advantage is expected to fuel the need for nootropics over the next six years. In addition, the growing use of the product among athletes and sports professionals, as well as among consumers for personal improvement, will have a positive impact on the market over the forecast period.
The growing geriatric population, coupled with the rising occurrence of various brain-related diseases, including dementia and other issues such as arthritis, has increased the need for nootropics. Moreover, these products are employed for the treatment of other cognitive and age-related disorders, including hyperactivity, as well as Parkinson's disease. Numerous consumers across the globe have been undergoing depression as well as other mood and emotional disorders. Thus, rising demand for mood enhancers is also expected to stimulate industry growth over the next six years.
Manufacturers are responding to the rising demand for nootropics by focusing on research and development, as well as new product launches, quality control, vegan and plant-based options, and specialized products for various niches. For instance, in August 2025, Unconform, formerly Impact Coffee, launched a nootropic-enhanced cold brew RTD coffee line designed to improve mental clarity, cognitive longevity, digestive, and immune health without typical caffeine side effects. The 250ml cans come in three flavors: Flat White (with Ashwagandha, Ginkgo Biloba & Vitamin B12), Salted Caramel Latte (with Inulin and Turmeric), and Mocha (with Niacin & Biotin), priced at £2.50 each. Additionally, Unconform offers Smart Sticks-neutral-flavored sachets that boost immunity, mental clarity, gut health, or beauty, priced at £7.99 for a box of 10 sachets.
Global Nootropics Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the global nootropics market report on the basis of form, distribution channel, and region:
- Form Outlook (Revenue, USD Million, 2021 - 2033)
- Capsules/Tablets
- Powder
- Drinks
- Others
- Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
- Offline
- Online
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia & New Zealand
- South Korea
- Central & South America
- Brazil
- Middle East & Africa
- UAE
Product Code: GVR-4-68039-914-3
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Products & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.6. Data Validation & Publishing
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Product Outlook
- 2.3. Distribution Channel Outlook
- 2.4. Regional Outlook
Chapter 3. Nootropics Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.2. Industry Value Chain Analysis
- 3.2.1. Sales/Retail Channel Analysis
- 3.2.2. Profit Margin Analysis
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.2. Market Restraint Analysis
- 3.3.3. Market Opportunities
- 3.3.4. Market Challenges
- 3.4. Industry Analysis - Porter's Five Forces Analysis
- 3.5. Market Entry Strategies
Chapter 4. Consumer Behavior Analysis
- 4.1. Demographics Analysis
- 4.2. Consumer Trends and Preferences
- 4.3. Factors Affecting Buying Decision
- 4.4. Consumer Product Adoption
- 4.5. Key Observations & Findings
Chapter 5. Nootropics Market: Form Estimates & Trend Analysis
- 5.1. Form Movement Analysis & Market Share, 2025 & 2033
- 5.2. Capsules/Tablets
- 5.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.3. Powder
- 5.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.4. Drinks
- 5.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.5. Others
- 5.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
Chapter 6. Nootropics Market: Distribution Channel Range Estimates & Trend Analysis
- 6.1. Distribution Channel Movement Analysis & Market Share, 2025 & 2033
- 6.2. Offline
- 6.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 6.3. Online
- 6.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
Chapter 7. Nootropics Market: Regional Estimates & Trend Analysis
- 7.1. Regional Movement Analysis & Market Share, 2025 & 2033
- 7.2. North America
- 7.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.2.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.2.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.2.4. U.S.
- 7.2.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.2.4.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.2.4.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.2.5. Canada
- 7.2.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.2.5.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.2.5.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.2.6. Mexico
- 7.2.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.2.6.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.2.6.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.3. Europe
- 7.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.3.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.3.4. Germany
- 7.3.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.4.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.3.4.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.3.5. U.K.
- 7.3.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.5.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.3.5.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.3.6. France
- 7.3.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.6.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.3.6.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.3.7. Italy
- 7.3.7.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.7.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.3.7.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.3.8. Spain
- 7.3.8.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.8.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.3.8.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.4. Asia Pacific
- 7.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.4.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.4.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.4.4. China
- 7.4.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.4.4.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.4.4.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.4.5. India
- 7.4.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.4.5.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.4.5.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.4.6. Japan
- 7.4.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.4.6.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.4.6.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.4.7. South Korea
- 7.4.7.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.4.7.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.4.7.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.4.8. Australia & New Zealand
- 7.4.8.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.4.8.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.4.8.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.5. Central & South America
- 7.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.5.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.5.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.5.4. Brazil
- 7.5.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.5.4.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.5.4.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.6. Middle East & Africa
- 7.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.6.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.6.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.6.4. UAE
- 7.6.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.6.4.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.6.4.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
Chapter 8. Competitive Analysis
- 8.1. Recent developments & impact analysis, by key market participants
- 8.2. Company Categorization
- 8.3. Participant's Overview
- 8.4. Financial Performance
- 8.5. Product Benchmarking
- 8.6. Company Market Share Analysis, 2025 (%)
- 8.7. Company Heat Map Analysis
- 8.8. Strategy Mapping
- 8.9. List of key companies analyzed in this section include:
- 8.9.1. Onnit Labs, Inc.
- 8.9.1.1. Company Overview
- 8.9.1.2. Financial Performance
- 8.9.1.3. Product Benchmarking
- 8.9.1.4. Strategic Initiatives
- 8.9.2. Reckitt Benckiser Group PLC
- 8.9.2.1. Company Overview
- 8.9.2.2. Financial Performance
- 8.9.2.3. Product Benchmarking
- 8.9.2.4. Strategic Initiatives
- 8.9.3. Mental Mojo, LLC
- 8.9.3.1. Company Overview
- 8.9.3.2. Financial Performance
- 8.9.3.3. Product Benchmarking
- 8.9.3.4. Strategic Initiatives
- 8.9.4. NooCube
- 8.9.4.1. Company Overview
- 8.9.4.2. Financial Performance
- 8.9.4.3. Product Benchmarking
- 8.9.4.4. Strategic Initiatives
- 8.9.5. Mind Lab Pro (Performance Lab Group Ltd)
- 8.9.5.1. Company Overview
- 8.9.5.2. Financial Performance
- 8.9.5.3. Product Benchmarking
- 8.9.5.4. Strategic Initiatives
- 8.9.6. TruBrain
- 8.9.6.1. Company Overview
- 8.9.6.2. Financial Performance
- 8.9.6.3. Product Benchmarking
- 8.9.6.4. Strategic Initiatives
- 8.9.7. Neu Mind, LLC
- 8.9.7.1. Company Overview
- 8.9.7.2. Financial Performance
- 8.9.7.3. Product Benchmarking
- 8.9.7.4. Strategic Initiatives
- 8.9.8. Nooflux LLC
- 8.9.8.1. Company Overview
- 8.9.8.2. Financial Performance
- 8.9.8.3. Product Benchmarking
- 8.9.8.4. Strategic Initiatives
- 8.9.9. Zhou Nutrition
- 8.9.9.1. Company Overview
- 8.9.9.2. Financial Performance
- 8.9.9.3. Product Benchmarking
- 8.9.9.4. Strategic Initiatives
- 8.9.10. Kimera Koffee
- 8.9.10.1. Company Overview
- 8.9.10.2. Financial Performance
- 8.9.10.3. Product Benchmarking
- 8.9.10.4. Strategic Initiatives
- 8.9.1. Onnit Labs, Inc.
Product Code: GVR-4-68039-914-3
List of Tables
- 1. Nootropics Market - Key market driver analysis
- 2. Nootropics Market - Key market restraint analysis
- 3. Capsules/tablets nootropics market estimates and forecast, 2021 - 2033 (USD Million)
- 4. Nootropics powder market estimates and forecast, 2021 - 2033 (USD Million)
- 5. Nootropics drinks market estimates and forecast, 2021 - 2033 (USD Million)
- 6. Other nootropics market estimates and forecast, 2021 - 2033 (USD Million)
- 7. Nootropics market estimates and forecast, through online, 2021 - 2033 (USD Million)
- 8. Nootropics market estimates and forecast, through offline, 2021 - 2033 (USD Million)
- 9. North America garage organization & storage market estimates and forecast, 2021 - 2033 (USD Million)
- 10. North America nootropics market, by form, 2021 - 2033 (USD Million)
- 11. North America nootropics market, by distribution channel, 2021 - 2033 (USD Million)
- 12. U.S. nootropics market estimates and forecast, 2021 - 2033 (USD Million)
- 13. U.S. nootropics market, by form, 2021 - 2033 (USD Million)
- 14. U.S. garage organization & storage market, by distribution channel, 2021 - 2033 (USD Million)
- 15. Canada nootropics market estimates and forecast, 2021 - 2033 (USD Million)
- 16. Canada nootropics market, by form, 2021 - 2033 (USD Million)
- 17. Canada nootropics market, by distribution channel, 2021 - 2033 (USD Million)
- 18. Mexico nootropics market estimates and forecast, 2021 - 2033 (USD Million)
- 19. Mexico nootropics market, by form, 2021 - 2033 (USD Million)
- 20. Mexico nootropics market, by distribution channel, 2021 - 2033 (USD Million)
- 21. Europe nootropics market estimates and forecast, 2021 - 2033 (USD Million)
- 22. Europe nootropics market, by form, 2021 - 2033 (USD Million)
- 23. Europe nootropics market, by distribution channel, 2021 - 2033 (USD Million)
- 24. U.K. nootropics market estimates and forecast, 2021 - 2033 (USD Million)
- 25. U.K. nootropics market, by form, 2021 - 2033 (USD Million)
- 26. U.K. nootropics market, by distribution channel, 2021 - 2033 (USD Million)
- 27. Germany nootropics market estimates and forecast, 2021 - 2033 (USD Million)
- 28. Germany nootropics market, by form, 2021 - 2033 (USD Million)
- 29. Germany nootropics market, by application, 2021 - 2033 (USD Million)
- 30. France nootropics market estimates and forecast, 2021 - 2033 (USD Million)
- 31. France nootropics market, by form, 2021 - 2033 (USD Million)
- 32. France garage organization & storage market, by distribution channel, 2021 - 2033 (USD Million)
- 33. Italy nootropics market estimates and forecast, 2021 - 2033 (USD Million)
- 34. Italy nootropics market, by form, 2021 - 2033 (USD Million)
- 35. Italy nootropics market, by distribution channel, 2021 - 2033 (USD Million)
- 36. Spain nootropics market estimates and forecast, 2021 - 2033 (USD Million)
- 37. Spain nootropics market, by form, 2021 - 2033 (USD Million)
- 38. Spain nootropics market, by distribution channel, 2021 - 2033 (USD Million)
- 39. Asia Pacific nootropics market estimates and forecast, 2021 - 2033 (USD Million)
- 40. Asia Pacific nootropics market, by form, 2021 - 2033 (USD Million)
- 41. Asia Pacific nootropics market, by distribution channel, 2021 - 2033 (USD Million)
- 42. India nootropics market estimates and forecast, 2021 - 2033 (USD Million)
- 43. India nootropics market, by form, 2021 - 2033 (USD Million)
- 44. India nootropics market, by distribution channel, 2021 - 2033 (USD Million)
- 45. China nootropics market estimates and forecast, 2021 - 2033 (USD Million)
- 46. China nootropics market, by form, 2021 - 2033 (USD Million)
- 47. China nootropics market, by distribution channel, 2021 - 2033 (USD Million)
- 48. Japan nootropics market estimates and forecast, 2021 - 2033 (USD Million)
- 49. Japan nootropics market, by form, 2021 - 2033 (USD Million)
- 50. Japan nootropics market, by distribution channel, 2021 - 2033 (USD Million)
- 51. South Korea nootropics market estimates and forecast, 2021 - 2033 (USD Million)
- 52. South Korea nootropics market, by form, 2021 - 2033 (USD Million)
- 53. South Korea nootropics market, by distribution channel, 2021 - 2033 (USD Million)
- 54. Australia & New Zealand nootropics market estimates and forecast, 2021 - 2033 (USD Million)
- 55. Australia & New Zealand nootropics market, by form, 2021 - 2033 (USD Million)
- 56. Australia & New Zealand nootropics market, by distribution channel, 2021 - 2033 (USD Million)
- 57. Central & South America nootropics market estimates and forecast, 2021 - 2033 (USD Million)
- 58. Central & South America nootropics market, by form, 2021 - 2033 (USD Million)
- 59. Central & South America nootropics market, by distribution channel, 2021 - 2033 (USD Million)
- 60. Brazil nootropics market estimates and forecast, 2021 - 2033 (USD Million)
- 61. Brazil nootropics market, by form, 2021 - 2033 (USD Million)
- 62. Brazil nootropics market, by distribution channel, 2021 - 2033 (USD Million)
- 63. Middle East & Africa nootropics market estimates and forecast, 2021 - 2033 (USD Million)
- 64. Middle East & Africa nootropics market, by form, 2021 - 2033 (USD Million)
- 65. Middle East & Africa nootropics market, by distribution channel, 2021 - 2033 (USD Million)
- 66. UAE nootropics market estimates and forecast, 2021 - 2033 (USD Million)
- 67. UAE nootropics market, by form, 2021 - 2033 (USD Million)
- 68. UAE nootropics market, by distribution channel, 2021 - 2033 (USD Million)
- 69. Vendor Landscape
List of Figures
- 1. Nootropics Market Snapshot
- 2. Nootropics Market segmentation & scope
- 3. Nootropics Market penetration & growth prospect mapping
- 4. Nootropics Market value chain analysis
- 5. Nootropics market dynamics
- 6. Nootropics Market Porter's analysis
- 7. Nootropics: Form (%) analysis, 2025 & 2033
- 8. Nootropics: Distribution Channel (%) analysis, 2025 & 2033
- 9. Nootropics: Regional (%) analysis, 2025 & 2033
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.